Научно-практический журнал Медицинские технологии. Оценка и выбор
  • Русский
  • English

Issue № 2 | 2019 (36)

DOI: https://doi.org/10.31556/2219-0678.2019.36.2.016-023 meta

Abstract

Sweden is one of the first countries who establish health technology assessment (HTA) agency. Nowadays, there are two HTA organizations in the country. The first is one of the oldest in the world – the Swedish agency for health technology assessment and assessment of social services (SBU), and the second is the Council The Dental and Pharmaceutical Benefits Agency (TLV). Having similar tasks, organizations are created for different purposes. TLV assesses medical technologies within state reimbursement system, its purpose is to ensure the efficient use of budget funds. The SBU does not participate in the reimbursement system and does not have any regulatory functions, its purpose is to respond to public inquiries regarding the use of any medical technology. Agencies differ in the number of annually published reports, their types and objects of evaluation. Wherein the work of both institutions is characterized by a wide involvement of independent experts, outside organizations and particular attention to the economic component of the assessment.

Keywords

HTA, reimbursement, Sweden healthcare system.

For citations

Omelyanovskiy V.V., Gorkavenko F.V., Saybel Y.S., Khachatryan G.R. Health Technology Assessment System in Sweden. Medical Technologies. Assessment and Choice. 2019; 2(36): 16–23.

Issue № 1 | 2019 (35)

DOI: https://doi.org/10.31556/2219-0678.2019.35.1.018-031 meta

Abstract

The article is a systematic review of the research devoted to the study of epidemiology, mechanisms of adverse events associated with the provision of medical care, as well as the principles of patient safety management. The meta-analysis allowed to establish that cases of harm in the provision of medical care (adverse events) are recorded in 10.6% of patients. At the heart of the development of adverse events are systemic causes – latent threats, the management of which is the basis of the modern strategy of ensuring the safety of medical care.

Keywords

medical care; patient safety; adverse events; latent threats, active threats, incident; unexpected death.

For citations

Voskanyan Yu.E., Shikina I.B. Health Care Safety Management in Modern Health Care. Medical Technologies. Assessment and Choice. 2019; 1(35): 18–31.

Issue № 33 | 2018 (3)

DOI: https://doi.org/10.31556/2219-0678.2018.33.3.018-027 meta

Abstract

The application of the nomenclature of medical services in the Russian Federation revealed limitations of its structure and content. The analysis of international experience in the classification of medical interventions can help to improve this nomenclature. World Health Organization has prepared a draft of the International Classification of Health Interventions (ICHI), which should be a part of a family of health-related international classifications. It is not yet finished and cannot be used for the classification of medical services on a national level; however, its main principles have already been formulated. All interventions are classified according to three levels (axes): target of intervention; action (the essence of intervention), and means. Lists of types of targets, actions and means have been developed, and recommendations on the classification and coding of medical interventions have been proposed for various situations. There are significant differences in the approach to the classification of medical interventions between ICHI and the Russian nomenclature of medical services. A detailed comparative analysis of the classification principles in ICHI and in the nomenclature is needed.

Keywords

nomenclature of medical services, classification, coding, World Health Organization, International Classification of Health Interventions.

For citations

Tyurina I. V. The Principles of International Classification of Health Interventions of World Health Organization. Medical Technologies. Assessment and Choice. 2018; 3(33): 18–27.

Issue № 32 | 2018 (2)

DOI: https://doi.org/10.31556/2219-0678.2018.32.2.034-041 meta

Abstract

The article discusses the health technology assessment (HTA) in Scotland. The HTA is provided by the Scottish Medicines Consortium (SMC), that gives recommendations on the use of new registered drugs in the National Health Service of Scotland. New forms of release and new indications for the use of already existing drugs are assessed as well. The SMC assesses only new prescription drugs but not vaccines, generic drugs or blood products. The assessment procedures are strictly regulated. The experts use the specially designed checklists. The assessment is carried out on the basis of the data submitted by the applicant and filled in accordance with the established form (dossier). Clinical efficacy, safety, clinical and economic advantages of the drug in question are assessed. The file review takes about 18 weeks. Based on the assessment results, the SMC makes a conclusion on the possibility of financing the drug at the expense of the state budget. The SMC ‘s conclusions are recommendations only, the final decisions on the state financing of the drug are taken at the meetings of the country’s territorial health councils.

Keywords

health technology assessment, the Scottish Medicines Consortium, clinical checklist, economics checklist.

For citations

Teptsova N. S., Lemeshko V. A. Health Technology Assessment in Scotland. Medical Technologies. Assessment and Choice. 2018; 2(32): 34–41

Issue № 31 | 2018 (1)

Abstract

Canada’s health care system is strongly decentralized. Regions independently define the amount of necessary medical care, which causes unequal distribution of medical services and drug supply. The key mechanism of the optimization of public funds and providing appropriate drug care is health technology assessment (HTA) performed independently by the Canadian Agency for Drugs and Technologies in Health (CADTH) using Common Drug Review (CDR) or pan-Canadian Oncology Drug Review (pCODR) procedures. Both reviews include the assessment of clinical and economic effectiveness of drugs and recommendations on reimbursement. Despite the advisory nature of these documents, almost all decisions on the inclusion into the lists of refunded drugs are based on the results of the conducted HTA.

Keywords

health technology assessment, reimbursement system, Canada’s health care system, drug supply.

For citations

Lemeshko V. A., Teptsova T. S. Drug Supply and Health Technology Assessment in Canada’s Health Care System. Medical Technologies. Assessment and Choice. 2018; 1(31): 30–39.

Issue № 30 | 2017 (4)

Abstract

Most countries today actively implement electronic health care technologies including telemedicine. Telemedicine has already increased the availability of medical care for the population of remote areas, the elderly, and the patients with reduced mobility. It also improved the quality of care due to counselling sessions between regional hospitals and leading medical centers. According to economic studies conducted in the U.S., Japan, and other countries, telemedicine has a significant economic potential both for the budget of health care system and for patients. There are examples of successful telemedicine projects in Russia. The use of the best foreign experience makes it possible to integrate telemedicine technologies into medical practice.

Keywords

telemedicine, electronic health care, foreign experience, efficiency.

For citations

Lemeshko V. A., Teptsova T. S. Telemedicine: a Step to the Future of Health Care. Medical Technologies. Assessment and Choice. 2017; 4(30): 30–38.

Issue № 28 | 2017 (2)

Abstract

The article analyzes the methods of pricing and price regulation of medicines used in foreign countries. In the world practice, various pricing methods are used, and often several approaches are used in the pricing system of the region. The main methods of pricing include: Rate of return regulation; External reference pricing; Internal reference pricing; Costs plus pricing; Value-based pricing; Alternative pricing schemes (risk sharing agreements).

Keywords

pharmaceutical pricing, reference pricing, reference price, value-based pricing, risk-sharing agreements, alternative pricing schemes.

For citations

Musina N. Z., Fedyaeva V. К., Ivahnenko О. I., Khachatryan G. R., Gerasimova К. V. Analysis of Pricing Schemes and Price Regulation of the Cost of Drugs in Foreign Countries. Medical Technologies. Assessment and Choice. 2017; 2(28): 30–39.

Issue № 28 | 2017 (2)

Abstract

A reform of medical care delivery is now conducted in the Russian health care system. It is largely connected with the growth of personal expenditures of patients on medical services, which requires the implementation of legal mechanisms of co-funding of medical care. The article analyses the international practices in health care funding, which may be of utmost importance to solve this task.

Keywords

health care model, health care system, co-funding of medical care, co-payments, medical co-insurance, funding and organization of medical care, sources of funding of health care, international practices.

For citations

Lukyantseva D. V., Tatarinov A. P., Melnikova L. S. International Practices in Funding of Health Care System. Medical Technologies. Assessment and Choice. 2017; 2(28): 20–29.

Issue № 26 | 2016 (4)

Abstract

The current legislation of the Russian Federation allows patients to pay for hospitality services associated with medical care. Also, it is possible to pay for medical services that are not included into the Program of State Guarantees of Free Medical Care for Russian Citizens (Program of State Guarantees). Almost all types of medical care are included into the Program of State Guarantees. However, according to the data of the Organization for Economic Co-operation and Development (OECD), the share of private expenditures on health care in Russia in 2014 was about 37.4% of all expenditures on health care, which was higher than the average level of private expenditures in OECD member states (27.3%). This statistics suggest the necessity of legalization of private payments for the medical care, and introduction of mechanisms of participation of citizens in legal private funding of medical services (full payment for some services), i.e. co-financing mechanisms. The article analyses the international experience in order to draw conclusions on the results of the introduction of the system of co-funding of medical care by population.

Keywords

co-funding of medical care by population, co-financing, co-payments, co-insurance, franchise, cost distribution methods, international experience, model of health care, health care system, funding and organization of medical care, sources of health care funding, positive and negative effects of the introduction of co-funding methods, regulator of the amount of medical care.

For citations

Tatarinov A. P., Lukyantseva D. V., Melnikova L. S. The Influence of Private Co-funding of Medical Care on the Effectiveness of Health Care Systems in Different Countries. Medical Technologies. Assessment and Choice. 2016; 4(26): 20–25.

Issue № 26 | 2016 (4)

Abstract

This publication reviews the experience of organization and functioning of structures that define (select), plan and control screening and prevention activities/programs in US, Canada, Netherlands and Germany healthcare. We describe the objectives and principles of the responsible authorities in the issuance of screening recommendations. It was found that this organizations consists of independent experts and issue recommendations based on strong scientific evidences and oriented to a specific target audience.

Keywords

task force, screening, prevention, examinations, recommendations, international experience.

For citations

Dombrovskiy V. S., Khachatryan G. R. Organization of the Evaluation of Screening Programs in the United States, Canada, the Netherlands and Germany. Medical Technologies. Assessment and Choice. 2016; 4(26): 11–19.